MedTrace Logo

Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation

NCT01444131 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 446

Last updated 2014-03-26

No results posted yet for this study

Summary

The purpose of this study is to test whether the addition of a nicotine patch to varenicline increases smoking cessation success rate and whether the combination is safe.

Conditions

  • Tobacco Dependence

Interventions

DRUG

Varenicline, Nicotine Patch

active nicotine patches added to varenicline.

DRUG

Varenicline and Placebo Patch

placebo nicotine patches added to varenicline.

Sponsors & Collaborators

  • QuitSupport

    collaborator UNKNOWN

  • University of Stellenbosch

    lead OTHER

Principal Investigators

  • Elvis M Irusen, MBChB, FCP, PhD · University of Stellenbosch

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-04-30
Completion
2013-06-30

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01444131 on ClinicalTrials.gov